Computed Tomography (CT) Systems Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Computed Tomography Systems Pipeline Market Report Overview

Computed Tomography (CT) is a powerful, non-destructive evaluation technique used for producing 2D and 3D cross-sectional images of an object from a flat X-ray image. It is used on patients with a high risk of colon cancer, or full-motion heart scans for patients with a high risk of heart disease. It can also be used to image complex fractures, detect infarction, tumors, calcifications, hemorrhage, bone trauma, and also acute and chronic changes in the lung parenchyma, etc. The device includes a slice detector and an X-ray source. 256-320 slice CT Systems, 128-slice CT Systems, 64-slice CT Systems, 20-40 slice CT Systems, and 16-slice and below CT Systems are tracked under this category. Tracked here under is the equipment only and not accessories and/or additional costs associated with CT installation.

The computed tomography systems pipeline market research report provides comprehensive information about the computed tomography systems pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Key Segments ·       64-slice CT Systems

·       16-slice and below CT Systems

Key Territories ·       The US

·       Europe

·       China

·       Japan

·       Australia

Key Regulatory Paths ·       510(k)

·       NMPA

·       CE

·       UKCA

·       TGA

Leading Companies ·       Advanced Breast-CT GmbH

·       Annalise-AI Pty Ltd

·       Bioptics Technology LLC

·       California Institute of Technology

·       Canon Medical Systems Corp

·       Canon Medical Systems USA Inc

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Computed Tomography Systems Pipeline Market Segments

Some of the key segments in the computed tomography systems pipeline market are 64-slice CT systems and 16-slice and below CT systems. As of May 2023, 64-slice CT systems have the highest number of pipeline products.

Computed Tomography Systems Pipeline Market Analysis, by Segments, 2023 (%)

Computed Tomography Systems Pipeline Market Analysis, by Segments, 2023 (%)

For more segment insights into the computed tomography systems pipeline market, download a free report sample

Computed Tomography Systems Pipeline Market Segmentation by Territories

Some of the territories in the computed tomography systems pipeline market are the US, Europe, China, Japan, and Australia among others. As of May 2023, the US has the highest number of pipeline products.

Computed Tomography Systems Pipeline Market Analysis, by Territories, 2023 (%)

Computed Tomography Systems Pipeline Market Analysis, by Territories, 2023 (%)

For more territory insights into the computed tomography systems pipeline market, download a free report sample

Computed Tomography Systems Pipeline Market Segmentation by Regulatory Paths

Some of the regulatory paths in the computed tomography systems pipeline market are 510(k), NMPA, UKCA, TGA, and CE. As of May 2023, 510(k) is the most followed pathway for pipeline products.

Computed Tomography Systems Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

Computed Tomography Systems Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

For more regulatory path insights into the computed tomography systems pipeline market, download a free report sample

Computed Tomography Systems Pipeline Market – Competitive Landscape

Some of the key companies in the computed tomography systems pipeline market are Advanced Breast-CT GmbH, Annalise-AI Pty Ltd, Bioptics Technology LLC, California Institute of Technology, Canon Medical Systems Corp, and Canon Medical Systems USA Inc among others.

Annalise-AI Pty Ltd Company Overview: Annalise-AI Pty Ltd (Annalise) is a developer of AI products to improve the delivery of medical imaging services. Annalise is headquartered in Sydney, New South Wales, Australia. Annalise CT Chest is intended for computed tomography image analysis. It is designed to identify and localize more than 100 clinical findings on CT chest images. It is based on Artificial Intelligence Technology.

Segments Covered in the Report

Computed Tomography Systems Pipeline Market Segments Outlook

  • 64-slice CT Systems
  • 16-slice and below CT Systems

Computed Tomography Systems Pipeline Market Territories Outlook

  • The US
  • Europe
  • China
  • Japan
  • Australia

Computed Tomography Systems Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • NMPA
  • CE
  • UKCA
  • TGA

Scope

  • Extensive coverage of the computed tomography systems under development
  • Reviews details of major pipeline products which include, product description, licensing and collaboration details, and other developmental activities
  • Reviews the major players involved in the development of computed tomography systems and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage
  • Identify and understand important and diverse types of computed tomography systems under development
  • Develop market-entry and market-expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date

Advanced Breast-CT GmbH
Annalise-AI Pty Ltd
Bioptics Technology LLC
California Institute of Technology
Canon Medical Systems Corp
Canon Medical Systems USA Inc
Duke University
Fermilab
FMI Medical Systems Inc
GE HealthCare Technologies Inc
German Cancer Research Center
Hitachi Medical Corp
Imatrex Inc
Izotropic Corp
Johns Hopkins University
Koning Corp
Koninklijke Philips NV
Malcova LLC
Massachusetts General Hospital
Micro-X Ltd
Nano Vision
Nanovision Technology Beijing Co Ltd
National Institutes of Health Clinical Center
NeuralRad LLC
Neusoft Medical Systems Co Ltd
Norsk Luftambulanse AS
Philips Healthcare
Shanghai United Imaging Healthcare Co Ltd
Siemens Healthineers AG
Stanford University
Stellarray, Inc.
TetraImaging LLC
The Hong Kong University of Science and Technology
The University of Manchester
Tribogenics, Inc.
United Imaging Systems (Beijing) Co Ltd
University Health Network
University of Antwerp
University of Auckland
University of California Santa Cruz
University of Louisville
University of Washington
Varex Imaging Corp
Varian Medical Systems Inc
Xoran Technologies LLC
ZumaTek, Inc.

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 7

|1.2 List of Figures 11

2 Introduction 12

2.1 Computed Tomography (CT) Systems Overview 12

3 Products under Development 13

3.1 Computed Tomography (CT) Systems – Pipeline Products by Stage of Development 13

3.2 Computed Tomography (CT) Systems – Pipeline Products by Segment 14

3.3 Computed Tomography (CT) Systems – Pipeline Products by Territory 15

3.4 Computed Tomography (CT) Systems – Pipeline Products by Regulatory Path 16

3.5 Computed Tomography (CT) Systems – Pipeline Products by Estimated Approval Date 17

3.6 Computed Tomography (CT) Systems – Ongoing Clinical Trials 18

4 Computed Tomography (CT) Systems – Pipeline Products under Development by Companies 19

4.1 Computed Tomography (CT) Systems Companies – Pipeline Products by Stage of Development 19

4.2 Computed Tomography (CT) Systems – Pipeline Products by Stage of Development 21

5 Computed Tomography (CT) Systems Companies and Product Overview 23

5.1 Advanced Breast-CT GmbH Company Overview 23

5.1.1 Advanced Breast-CT GmbH Pipeline Products & Ongoing Clinical Trials Overview 23

5.2 Annalise-AI Pty Ltd Company Overview 24

5.2.1 Annalise-AI Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 24

5.3 Bioptics Technology LLC Company Overview 25

5.3.1 Bioptics Technology LLC Pipeline Products & Ongoing Clinical Trials Overview 25

5.4 California Institute of Technology Company Overview 26

5.4.1 California Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 26

5.5 Canon Medical Systems Corp Company Overview 27

5.5.1 Canon Medical Systems Corp Pipeline Products & Ongoing Clinical Trials Overview 27

5.6 Canon Medical Systems USA Inc Company Overview 28

5.6.1 Canon Medical Systems USA Inc Pipeline Products & Ongoing Clinical Trials Overview 28

5.7 Duke University Company Overview 29

5.7.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 29

5.8 Fermilab Company Overview 30

5.8.1 Fermilab Pipeline Products & Ongoing Clinical Trials Overview 30

5.9 FMI Medical Systems Inc Company Overview 31

5.9.1 FMI Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 31

5.10 GE HealthCare Technologies Inc Company Overview 34

5.10.1 GE HealthCare Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 34

5.11 German Cancer Research Center Company Overview 38

5.11.1 German Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview 38

5.12 Hitachi Medical Corp Company Overview 39

5.12.1 Hitachi Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 39

5.13 Imatrex Inc Company Overview 40

5.13.1 Imatrex Inc Pipeline Products & Ongoing Clinical Trials Overview 40

5.14 Izotropic Corp Company Overview 41

5.14.1 Izotropic Corp Pipeline Products & Ongoing Clinical Trials Overview 41

5.15 Johns Hopkins University Company Overview 44

5.15.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 44

5.16 Koning Corp Company Overview 45

5.16.1 Koning Corp Pipeline Products & Ongoing Clinical Trials Overview 45

5.17 Koninklijke Philips NV Company Overview 46

5.17.1 Koninklijke Philips NV Pipeline Products & Ongoing Clinical Trials Overview 46

5.18 Malcova LLC Company Overview 48

5.18.1 Malcova LLC Pipeline Products & Ongoing Clinical Trials Overview 48

5.19 Massachusetts General Hospital Company Overview 49

5.19.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview 49

5.20 Micro-X Ltd Company Overview 50

5.20.1 Micro-X Ltd Pipeline Products & Ongoing Clinical Trials Overview 50

5.21 Nano Vision Company Overview 51

5.21.1 Nano Vision Pipeline Products & Ongoing Clinical Trials Overview 51

5.22 Nanovision Technology Beijing Co Ltd Company Overview 52

5.22.1 Nanovision Technology Beijing Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 52

5.23 National Institutes of Health Clinical Center Company Overview 53

5.23.1 National Institutes of Health Clinical Center Pipeline Products & Ongoing Clinical Trials Overview 53

5.24 NeuralRad LLC Company Overview 54

5.24.1 NeuralRad LLC Pipeline Products & Ongoing Clinical Trials Overview 54

5.25 Neusoft Medical Systems Co Ltd Company Overview 55

5.25.1 Neusoft Medical Systems Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 55

5.26 Norsk Luftambulanse AS Company Overview 56

5.26.1 Norsk Luftambulanse AS Pipeline Products & Ongoing Clinical Trials Overview 56

5.27 Philips Healthcare Company Overview 57

5.27.1 Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview 57

5.28 Shanghai United Imaging Healthcare Co Ltd Company Overview 58

5.28.1 Shanghai United Imaging Healthcare Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 58

5.29 Siemens Healthineers AG Company Overview 60

5.29.1 Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview 60

5.30 Stanford University Company Overview 66

5.30.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 66

5.31 Stellarray, Inc. Company Overview 68

5.31.1 Stellarray, Inc. Pipeline Products & Ongoing Clinical Trials Overview 68

5.32 TetraImaging LLC Company Overview 69

5.32.1 TetraImaging LLC Pipeline Products & Ongoing Clinical Trials Overview 69

5.33 The Hong Kong University of Science and Technology Company Overview 71

5.33.1 The Hong Kong University of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview 71

5.34 The University of Manchester Company Overview 72

5.34.1 The University of Manchester Pipeline Products & Ongoing Clinical Trials Overview 72

5.35 Tribogenics, Inc. Company Overview 73

5.35.1 Tribogenics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 73

5.36 United Imaging Systems (Beijing) Co Ltd Company Overview 74

5.36.1 United Imaging Systems (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 74

5.37 University Health Network Company Overview 77

5.37.1 University Health Network Pipeline Products & Ongoing Clinical Trials Overview 77

5.38 University of Antwerp Company Overview 78

5.38.1 University of Antwerp Pipeline Products & Ongoing Clinical Trials Overview 78

5.39 University of Auckland Company Overview 79

5.39.1 University of Auckland Pipeline Products & Ongoing Clinical Trials Overview 79

5.40 University of California Santa Cruz Company Overview 80

5.40.1 University of California Santa Cruz Pipeline Products & Ongoing Clinical Trials Overview 80

5.41 University of Louisville Company Overview 81

5.41.1 University of Louisville Pipeline Products & Ongoing Clinical Trials Overview 81

5.42 University of Washington Company Overview 82

5.42.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview 82

5.43 Varex Imaging Corp Company Overview 84

5.43.1 Varex Imaging Corp Pipeline Products & Ongoing Clinical Trials Overview 84

5.44 Varian Medical Systems Inc Company Overview 85

5.44.1 Varian Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 85

5.45 Xoran Technologies LLC Company Overview 86

5.45.1 Xoran Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 86

5.46 ZumaTek, Inc. Company Overview 88

5.46.1 ZumaTek, Inc. Pipeline Products & Ongoing Clinical Trials Overview 88

6 Computed Tomography (CT) Systems- Recent Developments 89

6.1 May 15, 2023: iCAD reports financial results for first quarter ended March 31, 2023 89

6.2 May 15, 2023: Fonar announces financial results for fiscal 2023 3rd quarter and nine-month period 90

6.3 May 15, 2023: Konica Minolta announces summary of consolidated financial results for the fiscal year ended March 31, 2023 92

6.4 May 11, 2023: Sanmina posts results for fiscal Q2 ended April 1, 2023 92

6.5 May 04, 2023: RaySearch Laboratories announces invitation to presentation of interim report for the first quarter of 2023 94

6.6 May 03, 2023: Glidewell to distribute CBCT imaging systems from carestream dental 94

6.7 Apr 28, 2023: Siemens to announce second quarter results FY 2023 94

6.8 Apr 26, 2023: RaySearch publishes preliminary results for the first quarter of 2023 95

6.9 Apr 25, 2023: OPKO Health to report Q1 2023 financial results on May 3, 2023 95

6.10 Apr 20, 2023: Median Technologies reports full-year 2022 results and business indicators for the First Quarter of 2023 95

6.11 Apr 20, 2023: EMIT IMAGING collaborates with MIT Koch institute for integrative cancer research to enhance cryo-fluorescence tomography technology 98

6.12 Apr 19, 2023: Voxeleron’s orion ophthalmic image analysis platform reduces variability of clinical trial outputs 98

6.13 Apr 18, 2023: RaySearch Laboratories Invitation to Annual General Meeting 2023 99

6.14 Apr 18, 2023: GE HealthCare introduces an innovative solution to help expand interventional CT access 103

6.15 Apr 17, 2023: iCAD Strengthens Leadership Team with Appointment of Chief Financial Officer and New Senior Executives 104

6.16 Apr 05, 2023: Philips leads in medical technology patents filed at the European Patent Office 105

6.17 Mar 28, 2023: Stryker announces Annual Meeting of Shareholders 106

6.18 Mar 27, 2023: iCad lays off 28% of its workforce in restructuring plan 106

6.19 Mar 13, 2023: iCAD Announces Leadership Transition 106

6.20 Mar 13, 2023: iCAD Previews Fourth Quarter Financial Results, Full Report on March 28, 2023 107

6.21 Feb 22, 2023: Qure.ai awarded EU MDR certification for its AI solutions 107

6.22 Feb 21, 2023: Accuray to Participate in the Cowen 43rd Annual Health Care Conference 108

6.23 Feb 16, 2023: OPKO Health to Report Fourth Quarter 2022 Financial Results on February 23, 2023 108

6.24 Feb 15, 2023: Xoran Technologies Expands Board of Managers 108

6.25 Feb 14, 2023: Siemens Limited announces Q1 FY 2023 results; 80% increase in PAT from continuing operations 109

6.26 Feb 14, 2023: Chest CT shows lung abnormalities two years after COVID 109

6.27 Feb 09, 2023: RaySearch Laboratories Invitation to presentation of year-end report 2022 110

6.28 Feb 08, 2023: Siemens Announces Earnings Release and Financial Results for the First Quarter of Fiscal Year 2023 110

6.29 Feb 08, 2023: Siemens Announces Earnings Release Q1 FY 2023 111

6.30 Feb 02, 2023: New 256-channel ADC from ams OSRAM reduces power and design complexity in high-performance CT detectors 113

6.31 Feb 02, 2023: Konica Minolta Announces Summary of Consolidated Financial Results for the Nine Months Ended December 31, 2022 114

6.32 Feb 01, 2023: Canon posts record revenues in medical business unit 116

6.33 Jan 31, 2023: RedPoint Medical 3D announces weight bearing CT, when available, is preferred input for its surgical planning solution 116

6.34 Jan 30, 2023: Philips to lay off 6,000 employees in drive to improve profitability 117

6.35 Jan 30, 2023: GE HealthCare Reports Fourth Quarter and Full Year 2022 Financial Results 117

6.36 Jan 30, 2023: Sanmina’s Announces First Quarter Fiscal 2023 Financial Results 120

6.37 Jan 26, 2023: CU research team moves one step closer to printing models of life-like 3D organs 122

6.38 Jan 19, 2023: Median Technologies Announces 2022 Revenue of €23.8 Million, up 16%, and an Order Backlog of €60.8 Million 123

6.39 Jan 19, 2023: New scan enables detection and cure of high blood pressure 123

6.40 Jan 17, 2023: GE HealthCare to Announce Fourth Quarter and Full Year 2022 Results on January 30, 2023 124

6.41 Jan 16, 2023: Ten-minute scan enables detection and cure of the commonest cause of high blood pressure 125

6.42 Jan 10, 2023: GE HealthCare Announces Preliminary Fourth Quarter and Full Year 2022 Revenue Results; Introduces 2023 Outlook 126

6.43 Jan 10, 2023: Accuray to Participate in the B. Riley Securities 3rd Annual Oncology Conference 127

6.44 Jan 05, 2023: GE HealthCare appoints former Amazon exec as first chief technology officer 127

6.45 Dec 19, 2022: Angelica Fuentes Joins Koning Board of Directors 127

6.46 Dec 14, 2022: AI model helps diagnose severity of COVID-19 pneumonia 127

6.47 Dec 12, 2022: Koning Corporation taps high-profile radiologists and researchers to join Scientific Advisory Board 128

6.48 Nov 30, 2022: Mark Burgess Named President North America, Agfa HealthCare 129

6.49 Nov 29, 2022: RaySearch Laboratories Announces Interim report July – September 2022 129

6.50 Nov 28, 2022: Canon Medical launches non-obsolescence program to help customers stay at forefront of care delivery 130

6.51 Nov 22, 2022: Samsung’s latest best-in-class technologies take center stage at RSNA 2022 131

6.52 Nov 22, 2022: Canon Medical Systems showcases meaningful innovation in its suite of solutions and products at RSNA 2022 133

6.53 Nov 17, 2022: Siemens reports outstanding performance in fiscal 2022 134

6.54 Nov 16, 2022: RaySearch publishes preliminary results for third quarter 2022 and postpones reporting date 136

6.55 Nov 16, 2022: Supervisory Board renews the term of office of Judith Wiese, Managing Board Member and Chief People & Sustainability Officer 136

6.56 Nov 14, 2022: FONAR Announces First Fiscal Quarter Earnings 137

6.57 Nov 10, 2022: iCAD Reports Financial Results for Third Quarter Ended September 30, 2022 138

6.58 Nov 09, 2022: Detection Technology complements its standard medical CT offering with X-ACE 16 HD 140

6.59 Nov 07, 2022: First domestically produced X-ray CT system with photon-counting detector installed at National Cancer Center Japan Exploratory Oncology Research & Clinical Trial Center 141

6.60 Oct 31, 2022: Siemens appoints Hakan Ozdemir as CEO in Qatar 142

6.61 Oct 30, 2022: Siemens appoints Jamie Hoyzer as CEO in Oman 142

6.62 Oct 27, 2022: iCAD to Report Third Quarter 2022 Financial Results on November 10, 2022 142

6.63 Oct 24, 2022: Philips To Cut 4000 Jobs As Company Faces Multiple Challenges 143

6.64 Oct 24, 2022: Bruker Receives Investment of $1.40 Million from Assenagon Asset Management S.A. 143

6.65 Oct 20, 2022: Median Technologies Announces Its 2022 Half-year Results and Revenues for the Third Quarter 143

6.66 Oct 20, 2022: X-ray Digital Twin for Digital Radiography & Computed Tomography Systems 145

6.67 Oct 18, 2022: Shimadzu Announces 1st Half Results & Financial Position for the Fiscal Year Ending March 2022 145

6.68 Oct 13, 2022: GE Healthcare announces multi-year agreement with SQM to secure iodine supply for contrast media 145

6.69 Oct 12, 2022: Philips provides update on its financial performance in Q3 2022 146

6.70 Oct 11, 2022: RaySearch Laboratories announces Invitation to Extraordinary General Meeting 2022 147

6.71 Sep 30, 2022: Eckard Eberle appointed as new CEO of Siemens Global Business Services 150

6.72 Sep 27, 2022: FONAR Announces Fiscal 2022 Financial Results 151

6.73 Aug 26, 2022: Konica Minolta Appoints New Head of Growing It Services Division 155

6.74 Aug 18, 2022: Philips to convene Extraordinary General Meeting of Shareholders to appoint Roy Jakobs as new President and Chief Executive Officer 156

6.75 Aug 10, 2022: Two Monumental milestones achieved in CT Imaging 156

6.76 Aug 05, 2022: Shimadzu Consolidated Financial Results for the Three Months Ended June 30, 2022 158

6.77 Aug 02, 2022: Fox Chase Cancer Center Welcomes Dr. Nithya Cherukuru 158

6.78 Aug 01, 2022: Sanmina reports financial results for fiscal Q3 ended July 2, 2022 159

6.79 Jul 27, 2022: iCAD to Report Second Quarter 2022 Financial Results on August 10, 2022 160

6.80 Jul 26, 2022: Siemens to Announce Third Quarter Results FY 2022 160

6.81 Jul 13, 2022: TeraRecon announces DocPanel signs Contract for Intuition Titanium, Reaffirming its Cardiothoracic Imaging Service Commitment 160

6.82 Jul 11, 2022: Median Technologies Communicates Its Business Indicators for the Second Quarter of 2022 161

6.83 Jul 11, 2022: 3DR Labs introduces new imaging services to meet specific radiology market needs 162

6.84 Jun 27, 2022: ProtOnART – a new consortium for proton online adaptive radiation therapy 163

6.85 Jun 13, 2022: Canon Medical Systems Canada in partnership with Harley Street Healthcare Group Canada to launch integrated community diagnostic centres across Ontario 164

6.86 Jun 02, 2022: Median Technologies to present an abstract at the 2022 ASCO Annual Meeting, June 3 – 7, 2022, McCormick Place, Chicago, IL, USA 165

7 Appendix 166

7.1 Methodology 166

7.2 About GlobalData 169

7.3 Contact Us 169

7.4 Disclaimer 169

Table

Computed Tomography (CT) Systems – Pipeline Products by Stage of Development 13

Computed Tomography (CT) Systems – Pipeline Products by Segment 14

Computed Tomography (CT) Systems – Pipeline Products by Territory 15

Computed Tomography (CT) Systems – Pipeline Products by Regulatory Path 16

Computed Tomography (CT) Systems – Pipeline Products by Estimated Approval Date 17

Computed Tomography (CT) Systems – Ongoing Clinical Trials 18

Computed Tomography (CT) Systems Companies – Pipeline Products by Stage of Development 19

Computed Tomography (CT) Systems – Pipeline Products by Stage of Development 21

Advanced Breast-CT GmbH Pipeline Products & Ongoing Clinical Trials Overview 23

nu:view – Product Status 23

nu:view – Product Description 23

Annalise-AI Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 24

Annalise CT Chest – Product Status 24

Annalise CT Chest – Product Description 24

Bioptics Technology LLC Pipeline Products & Ongoing Clinical Trials Overview 25

High-Density Optical Tomography Device – Product Status 25

High-Density Optical Tomography Device – Product Description 25

California Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 26

PACT – Breast Cancer – Product Status 26

PACT – Breast Cancer – Product Description 26

Canon Medical Systems Corp Pipeline Products & Ongoing Clinical Trials Overview 27

Angiographic Computed Tomography Device – Product Status 27

Angiographic Computed Tomography Device – Product Description 27

Canon Medical Systems USA Inc Pipeline Products & Ongoing Clinical Trials Overview 28

Infinix 4DCT – SURE Guidance – Product Status 28

Infinix 4DCT – SURE Guidance – Product Description 28

Duke University Pipeline Products & Ongoing Clinical Trials Overview 29

Computed Tomography – Nanoprobe – Product Status 29

Computed Tomography – Nanoprobe – Product Description 29

Fermilab Pipeline Products & Ongoing Clinical Trials Overview 30

Next-generation Detector And Imaging System – Product Status 30

Next-generation Detector And Imaging System – Product Description 30

FMI Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 31

FMI ScintiStar HPX CT – Product Status 31

FMI ScintiStar HPX CT – Product Description 31

FMI ScintiStar HPX PET/CT – Product Status 32

FMI ScintiStar HPX PET/CT – Product Description 32

FMI ScintiStar LPX CT – Product Status 32

FMI ScintiStar LPX CT – Product Description 33

GE HealthCare Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 34

Photon Counting Computed Tomography System – Product Status 34

Photon Counting Computed Tomography System – Product Description 34

TrueFidelity – GSI – Product Status 35

TrueFidelity – GSI – Product Description 35

GE HealthCare Technologies Inc – Ongoing Clinical Trials Overview 36

Photon Counting Computed Tomography System – Clinical Data Collection On Advanced CT System 37

Photon Counting Computed Tomography System – Spectral Computed Tomography with Photon-counting Detector 37

German Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview 38

4D Imaging Device – Product Status 38

4D Imaging Device – Product Description 38

Hitachi Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 39

PCCT System – Product Status 39

PCCT System – Product Description 39

Imatrex Inc Pipeline Products & Ongoing Clinical Trials Overview 40

TumoTrack – Product Status 40

TumoTrack – Product Description 40

Izotropic Corp Pipeline Products & Ongoing Clinical Trials Overview 41

Izoview – Product Status 41

Izoview – Product Description 41

Izotropic Corp – Ongoing Clinical Trials Overview 42

Izoview – Study on IzoView Imaging Platform in Detection and Diagnosis of Breast Cancer 43

Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 44

Beam Modulation Computed Tomography – Product Status 44

Beam Modulation Computed Tomography – Product Description 44

Koning Corp Pipeline Products & Ongoing Clinical Trials Overview 45

Next-Generation Breast CT – Product Status 45

Next-Generation Breast CT – Product Description 45

Koninklijke Philips NV Pipeline Products & Ongoing Clinical Trials Overview 46

CT 5100 Incisive With CT Smart Workflow – Product Status 46

CT 5100 Incisive With CT Smart Workflow – Product Description 46

SmartCT – Product Status 47

SmartCT – Product Description 47

Malcova LLC Pipeline Products & Ongoing Clinical Trials Overview 48

Breast-CT System – Product Status 48

Breast-CT System – Product Description 48

Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview 49

HPCC – Visual Colonoscopy Decision Support System – Product Status 49

HPCC – Visual Colonoscopy Decision Support System – Product Description 49

Micro-X Ltd Pipeline Products & Ongoing Clinical Trials Overview 50

Ring Scanner – Product Status 50

Ring Scanner – Product Description 50

Nano Vision Pipeline Products & Ongoing Clinical Trials Overview 51

Compound Eye 24 – Product Status 51

Compound Eye 24 – Product Description 51

Nanovision Technology Beijing Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 52

CT Scanner – Product Status 52

CT Scanner – Product Description 52

National Institutes of Health Clinical Center Pipeline Products & Ongoing Clinical Trials Overview 53

Photon-Counting Detector CT Scanner – Product Status 53

Photon-Counting Detector CT Scanner – Product Description 53

NeuralRad LLC Pipeline Products & Ongoing Clinical Trials Overview 54

Chest CT – Product Status 54

Chest CT – Product Description 54

Neusoft Medical Systems Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 55

512 Multi-Slice CT Scanner – Product Status 55

512 Multi-Slice CT Scanner – Product Description 55

Norsk Luftambulanse AS Pipeline Products & Ongoing Clinical Trials Overview 56

Pre-Hospital CT Scanner – Product Status 56

Pre-Hospital CT Scanner – Product Description 56

Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview 57

Multicolor CT Imaging Device – Product Status 57

Multicolor CT Imaging Device – Product Description 57

Shanghai United Imaging Healthcare Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 58

Deep Recon – Product Status 58

Deep Recon – Product Description 58

uCT ATLAS – 4cm – Product Status 59

uCT ATLAS – 4cm – Product Description 59

Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview 60

kVision Kilovoltage Cone Beam System – Product Status 60

kVision Kilovoltage Cone Beam System – Product Description 60

Lateral Plane Syngo DynaCT For ARTIS Icono – Product Status 61

Lateral Plane Syngo DynaCT For ARTIS Icono – Product Description 61

Photon Counting Detector – Product Status 61

Photon Counting Detector – Product Description 62

Somatom X.ceed – Product Status 62

Somatom X.ceed – Product Description 62

Siemens Healthineers AG – Ongoing Clinical Trials Overview 63

Lateral Plane Syngo DynaCT For ARTIS Icono – Prospective Evaluation of the Diagnostic Accuracy of Sine Spin Noncontrast Flat-Detector CT (FDCT) for the Detection of Intracranial Hemorrhage in Stroke Patients 64

Photon Counting Detector – Comprehensive Characterization of Coronary Atherosclerotic Disease Using Photon Counting- Detector Dual-source CT and Its Impact on Patient Management 65

Stanford University Pipeline Products & Ongoing Clinical Trials Overview 66

Cone Beam CT Imaging – Product Status 66

Cone Beam CT Imaging – Product Description 66

Weight-Bearing Computed Tomography – Product Status 67

Weight-Bearing Computed Tomography – Product Description 67

Stellarray, Inc. Pipeline Products & Ongoing Clinical Trials Overview 68

Digital Tomosynthesis X-Ray System – Product Status 68

Digital Tomosynthesis X-Ray System – Product Description 68

TetraImaging LLC Pipeline Products & Ongoing Clinical Trials Overview 69

ENT-TBCT – Product Status 69

ENT-TBCT – Product Description 69

Tetrahedron Beam Computed Tomography Device – Product Status 70

Tetrahedron Beam Computed Tomography Device – Product Description 70

The Hong Kong University of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview 71

CMOS CT Scanner – Product Status 71

CMOS CT Scanner – Product Description 71

The University of Manchester Pipeline Products & Ongoing Clinical Trials Overview 72

3D Heart Scan – Product Status 72

3D Heart Scan – Product Description 72

Tribogenics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 73

X-Ray Imaging Device – Osteoporosis CT Device – Product Status 73

X-Ray Imaging Device – Osteoporosis CT Device – Product Description 73

United Imaging Systems (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 74

uCT ATLAS With uWS-CT-Dual Energy Analysis – Product Status 74

uCT ATLAS With uWS-CT-Dual Energy Analysis – Product Description 74

United Imaging Systems (Beijing) Co Ltd – Ongoing Clinical Trials Overview 75

uCT ATLAS With uWS-CT-Dual Energy Analysis – Evaluation of a New Deep-learning Based Artificial Intelligence Iterative Reconstruction (AIIR) Algorithm in Different Enhancement Phases of Low-dose Liver CT 76

University Health Network Pipeline Products & Ongoing Clinical Trials Overview 77

Ultra-Fast Compressed Sensing Tomography Software – Product Status 77

Ultra-Fast Compressed Sensing Tomography Software – Product Description 77

University of Antwerp Pipeline Products & Ongoing Clinical Trials Overview 78

Tomographic Visualization Device – Product Status 78

Tomographic Visualization Device – Product Description 78

University of Auckland Pipeline Products & Ongoing Clinical Trials Overview 79

Breast Imaging Device – Product Status 79

Breast Imaging Device – Product Description 79

University of California Santa Cruz Pipeline Products & Ongoing Clinical Trials Overview 80

Proton CT Scanner – Product Status 80

Proton CT Scanner – Product Description 80

University of Louisville Pipeline Products & Ongoing Clinical Trials Overview 81

Computer-Aided Diagnosis Tool – Product Status 81

Computer-Aided Diagnosis Tool – Product Description 81

University of Washington Pipeline Products & Ongoing Clinical Trials Overview 82

Diagnostic Device – Breast Cancer – Product Status 82

Diagnostic Device – Breast Cancer – Product Description 82

Diagnostic Device – Skin Cancer – Product Status 83

Diagnostic Device – Skin Cancer – Product Description 83

Varex Imaging Corp Pipeline Products & Ongoing Clinical Trials Overview 84

Direct Conversion XC-THOR.CT Detector – Product Status 84

Direct Conversion XC-THOR.CT Detector – Product Description 84

Varian Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 85

4D Cone-Beam CT – Product Status 85

4D Cone-Beam CT – Product Description 85

Xoran Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 86

Computed Tomography Perfusion Device – Product Status 86

Computed Tomography Perfusion Device – Product Description 86

Thoracic CT System – Product Status 87

Thoracic CT System – Product Description 87

ZumaTek, Inc. Pipeline Products & Ongoing Clinical Trials Overview 88

X-Ray CT Scanner – Product Status 88

X-Ray CT Scanner – Product Description 88

Glossary 168

Figures

Computed Tomography (CT) Systems – Pipeline Products by Stage of Development 13

Computed Tomography (CT) Systems – Pipeline Products by Segment 14

Computed Tomography (CT) Systems – Pipeline Products by Territory 15

Computed Tomography (CT) Systems – Pipeline Products by Regulatory Path 16

Computed Tomography (CT) Systems – Pipeline Products by Estimated Approval Date 17

Computed Tomography (CT) Systems – Ongoing Clinical Trials 18

Frequently asked questions

Computed Tomography (CT) Systems Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Computed Tomography (CT) Systems Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Computed Tomography (CT) Systems Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Computed Tomography (CT) Systems Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.